Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Contract Formulation Company Profile – Lyophilization Services of New England

By Drug Discovery Trends Editor | March 4, 2009

Lyophilization Services of New England, Inc.
Lyophilization Services of New England, Inc.

Headquarters
Manchester, NH

Location(s)
Manchester, NH

Years in Drug Formulation
10 Years

Home

Areas of research

Small Molecule  

Biological  

Other

 

Drug Formulation Services Offered
• Analytical method development    • Bioavailability enhancement

•

Compatibility studies of active ingredients   

•

Dosage form selection

•

Excipient compatibility   

•

Formulation optimization

•

Formulation stress testing   

•

in silico studies

•

Manufacture of clinical supplies   

Novel delivery system

•

Packaging compatibility assessment   

•

Particle size reduction

•

Preclinical studies   

•

Solubilizing water-insoluble drugs

Stability studies   

Taste masking/flavorings

 

 

 

 

 

 

 

 

 

Other Services Offered
Disease Research    Target Identification

Lead Identification   

Early Safety Tests

Lead Optimization   

•

Pre-clinical Studies

IND Submission   

Clinical Trials

NDA Submission   

Post-marketing Studies

OTHER   

 

 

 

 

 

 

 

 

 

Types of Drugs

•

Generics  

•

Prescription  

•

OTC

 

Dosage Forms
Capsules    Implantable

Inhalation   

•

Injectible

Oral   

•

Parenteral

•

Peptide and Protein   

Tablets

•

Topical   

OTHER

 

 

 

 

 

 

Company’s role in drug discovery and developmnet
Lyophilization Services of New England, Inc. (LSNE) has provided CGMP contract manufacturing services since 1997. LSNE offers process development, aseptic and non-aseptic liquid filling into vials and custom containers, as well as dose or bulk lyophilization services to the biotechnology and pharmaceutical industries. LSNE’s three integrated manufacturing facilities and combined processing capacity make it one of the industries leading FDA inspected fill/finish providers. With 2,000 total sq. ft. of shelf space capacity in 19 lyophilization units, as well as 17 aseptic/non-aseptic processing suites, LSNE continues to offer quality consciousness, pre-clinical to commercial scale contract manufacturing services.


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE